Latest filing published 15 Jan 2021 for GlaxoSmithKline plc, €8,441.
Insider track record
D Connor: trading record in brief
D Connor appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). In total, 7 filings cover trades dated from 11 October 2018 to 14 January 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 15 January 2021: a share grant of €8,441, in GlaxoSmithKline plc. Typically, a trade is published a median of 5 days after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to D Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 542 shares@ £13.8802London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847478-5
- 523 shares@ £14.19London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746889-5
- 455 shares@ £16.1054100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3653560-5
- 570 shares@ £15.3297London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3561637-5
- 400 shares@ £17.903117.9% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200113110138_14381536_20200331164951975_11111-5
- 896 shares@ £15.299565.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190115144734_13935414_20200326185116249_17436-2
- 917 shares@ £14.747539.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20181017113001_13832379_20200330111442751_12873-2
7 of 7 declarations